Highlights
Profile claimed by owner
About
Drug Therapies for Treatment of Neurological Conditions
Clexio Biosciences is a clinical-stage pharmaceutical company developing CNS therapies designed to address patients unmet needs through a scientifically based fusion of drugs and innovative technologies. Clexios growing pipeline is focused on the development of safe and effective treatments with rapid onset of action for a wide range of neurological and psychiatric conditions, including major depressive disorder, Parkinsons disease, pain, and other conditions involving impairment of the neurological system.
Identity
| Name | Clexio Biosciences |
|---|---|
| Slug | clexio-biosciences |
| Type / kind | startup |
| Crunchbase ID | clexio-biosciences |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJmq3tMLDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Petah Tikva |
| HQ address | Yegi'a Kapayim St 17, Petah Tikva, Israel |
Web & social
| Website | https://www.clexio.com/ |
|---|---|
| Careers page | https://www.clexio.com/careers |
| https://www.linkedin.com/company/33519910 | |
| YouTube | https://www.youtube.com/channel/UCscUGnbNfBXUvBlySrWBekQ |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
pharmaceuticalstherapeuticsparkinsonpatientspain-reliefmental-healthcns-disordersdrug-discoverytreatmentsbioconvergence
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}